Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Docetaxel|DRUG: Carboplatin|DRUG: Herceptin|DRUG: Vinorelbine
Sponsor: Hellenic Oncology Research Group
Collaborators: University Hospital of Crete